CML is characterized by the t(9;22) (q34;q11) balanced reciprocal translocation of the Philadelphia (Ph) chromosome, which leads to the generation of the BCR::ABL oncogenic fusion gene encoding the chimeric BCR::ABL protein with constitutive kinase activity 3. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.